ARCHIVES

Nexavar Improves PFS In HER-2 Negative Breast Cancer

This article is from The Cancer Letter archive.

Vol. 34 No. 5 | May 27, 2011

Download PDF Visit The Full Archive

Related Articles

Drug Cleared For GIST And Kidney Cancer, FDA’s First Two-Indication Cancer Approval

January 27, 2006

Phase III Alimta Trial Fails To Extend Progression-Free Survival Without Grade 4 Adverse Events

June 28, 2013

What Would You Tell a 45-Year-Old? Waxman Asks Broder

February 4, 1994

HHS Plan Ties Breast Screening; Mammography Quality

July 16, 1993

Senate Calls Cancer Research a Priority, Cites Research Task Force Funding Goal

October 8, 1999

Funding Opportunities; Program Announcements Released By NCI

May 21, 1999